0001179110-14-018246.txt : 20141216 0001179110-14-018246.hdr.sgml : 20141216 20141216163648 ACCESSION NUMBER: 0001179110-14-018246 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141215 FILED AS OF DATE: 20141216 DATE AS OF CHANGE: 20141216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOSPIRA INC CENTRAL INDEX KEY: 0001274057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 FIELD DR CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 8479376472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Werner Thomas E CENTRAL INDEX KEY: 0001372882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31946 FILM NUMBER: 141290045 MAIL ADDRESS: STREET 1: C/O HOSPIRA, INC. STREET 2: 275 NORTH FIELD DRIVE CITY: LAKE FOREST STATE: IL ZIP: 60045 4 1 edgar.xml FORM 4 - X0306 4 2014-12-15 0 0001274057 HOSPIRA INC HSP 0001372882 Werner Thomas E C/O HOSPIRA, INC. 275 NORTH FIELD DRIVE LAKE FOREST IL 60045 0 1 0 0 SVP, Finance & CFO Common Stock 2014-12-15 4 M 0 10000 43.180 A 64614 D Common Stock 2014-12-15 4 S 0 9100 60.803 D 55514 D Common Stock 2014-12-15 4 S 0 900 61.387 D 54614 D Stock Options (Right to Buy) 43.180 2014-12-15 4 M 0 10000 0 D 2015-03-05 Common Stock 10000 11566 D Exercise of derivative security exempted pursuant to Rule 16b-3. The stock options vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on March 5, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.31 to $61.29, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.31 to $61.48, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote. Traded pursuant to a 10b5-1 plan. Benjamin Kwakye, Attorney in Fact 2014-12-16